copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Shinya Yamanaka - Wikipedia Yamanaka focused on factors that are important for maintaining pluripotency in embryonic stem (ES) cells This was the first time an intact differentiated somatic cell could be reprogrammed to become pluripotent
Shinya Yamanaka | Japanese Stem Cell Scientist | Britannica Shinya Yamanaka (born September 4, 1962, Ōsaka, Japan) is a Japanese physician and researcher who developed a revolutionary method for generating stem cells from existing cells of the body
Shinya Yamanaka – Facts - NobelPrize. org Yamanaka has been affiliated with Kyoto University since 2004 Shinya Yamanaka is married with two daughters Our lives begin when a fertilized egg divides and forms new cells that, in turn, also divide These cells are identical in the beginning, but become increasingly varied over time
Shinya Yamanaka | Gladstone Institutes In 2006, Shinya Yamanaka discovered that adult somatic cells can be reprogrammed into an embryonic-like pluripotent state by delivering transcription factors
Shinya Yamanaka | UCSF Profiles Dr Shinya Yamanaka is a Senior Investigator and the L K Whittier Foundation Investigator in Stem Cell Biology at the Gladstone Institute for Cardiovascular Disease (GICD)
Shinya Yamanaka, M. D. , Ph. D. | Academy of Achievement By the end of the year, Yamanaka had duplicated the results with human cells His discovery was hailed by scientists and religious leaders as a breakthrough that overcame the moral objection to stem cell research
Shinya Yamanaka – NAS In 2012, Dr Yamanaka was awarded the Nobel Prize in Physiology or Medicine for his discovery that adult somatic cells can be reprogrammed into pluripotent cells
Shinya Yamanaka | Research Starters - EBSCO For his groundbreaking contributions to medicine, Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 His work continues to influence research aimed at treating various human diseases, including amyotrophic lateral sclerosis (ALS) and other serious conditions